CDKN2A and neoplasm: The assessment of CDKN2A expression in HNSCC presents significant challenges, primarily due to the heterogeneity of tumour tissues and the limitations of traditional detection methods, which often require invasive biopsies and can yield variable results due to differences in technique sensitivity and specificity.